BCL3 and head and neck cancer: Furthermore, our study highlights a set of data to support the use of BCL3 mRNA expression as a biomarker of ESCC detection, suggesting further studies should be performed to corroborate these findings in high-risk groups for ESCC development, as head and neck cancer patients.